| Patents for C07K - Peptides (3,738) |
|---|
| 06/30/2005 | WO2005058939A2 Methods and compositions for inhibition of bcl6 repression |
| 06/30/2005 | WO2005058938A2 Helical synthetic peptides that stimulate cellular cholesterol efflux |
| 06/30/2005 | WO2005058937A2 A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1 |
| 06/30/2005 | WO2005042560A3 Non-viral delivery of compounds to mitochondria |
| 06/30/2005 | WO2005021576A3 Methods for for modeling gpcrs and for producing ligand blocking and receptor activating antibodies for same |
| 06/30/2005 | US20050142617 gene related to bone density; possible use in the drug screening, treatment, and diagnosis of bone disorders such as osteoporosis |
| 06/30/2005 | US20050142098 Polyoxyethylene glycol conjugated neublastin polypeptide dimers; exhibit prolonged bioavailability |
| 06/30/2005 | CA2549552A1 A.beta. immunogenic peptide carrier conjugates and methods of producing same |
| 06/30/2005 | CA2549529A1 Helical synthetic peptides that stimulate cellular cholesterol efflux |
| 06/30/2005 | CA2547635A1 A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1 |
| 06/29/2005 | EP1272507B1 Integrin binding peptide derivatives |
| 06/23/2005 | WO2005056578A2 High-level expression of fusion polypeptides in plant seeds utilizing seed-storage proteins as fusion carriers |
| 06/23/2005 | WO2005056577A2 Peptide inhibitors of hiv |
| 06/23/2005 | WO2005056576A2 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 06/23/2005 | WO2005056575A2 INTEGRIN αIIbβ3 SPECIFIC ANTIBODIES AND PEPTIDES |
| 06/23/2005 | WO2005056574A2 Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders |
| 06/23/2005 | US20050137133 nonimmunogenic water soluble polypeptides coupled to hydrophilic polymers, used as thrombopoietin agonist for the treatment of thrombocytopenia; blood disorders |
| 06/23/2005 | US20050136488 Identifying population of cells expressing fusion protein construct via fluorescent signal; diagnosing cancer |
| 06/23/2005 | US20050136070 Isolation and characterization of the csa operon (ETEC-CS4 Pili) and methods of using same |
| 06/23/2005 | CA2549391A1 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 06/23/2005 | CA2548749A1 High-level expression of fusion polypeptides in plant seeds utilizing seed-storage proteins as fusion carriers |
| 06/23/2005 | CA2548310A1 Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders |
| 06/23/2005 | CA2548243A1 Integrin aiib.beta.3 specific antibodies and peptides |
| 06/22/2005 | EP1543166A2 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 06/22/2005 | EP1542720A2 Treatment of tnf alpha related disorders |
| 06/22/2005 | CN1630721A Factor VII polypeptides for preventing formation of inhibitors in subjects with haemophilia |
| 06/16/2005 | WO2005054272A2 Human immunodeficiency virus entry inhibitor assay |
| 06/16/2005 | WO2005037857A3 Method of protein analysis by maldi using protein fragmentation with peroxycarbonates |
| 06/16/2005 | US20050129678 Using computer modeling to postulate amino acid composition of protein binding sites; bioinformatic and rational drug design |
| 06/15/2005 | EP1540015A2 Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents |
| 06/15/2005 | EP1539214A2 Thrombin peptide derivatives |
| 06/15/2005 | CN1626238A Composition of multiple scattered mixture contg.polypeptide and its pharm compsn. |
| 06/14/2005 | US6906320 Mass spectrometry data analysis techniques |
| 06/14/2005 | CA2100423C Parathyroid hormone analogs having parathyroid hormone-like activity |
| 06/09/2005 | WO2005051978A2 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof |
| 06/09/2005 | WO2005051977A2 Conditional allele system |
| 06/09/2005 | WO2005051976A2 Protein and peptide ligation processes and one-step purification processes |
| 06/09/2005 | WO2005051974A2 Novel molecules for regulating cell death |
| 06/09/2005 | WO2005051973A2 Peptides derived from natural cytotoxicity receptors and methods of use thereof |
| 06/09/2005 | WO2005028499A3 Peptide that binds to a broadly neutralizing anti-hiv antibody-structure of 4e10 fab fragment complex, uses thereof, compositions therefrom |
| 06/09/2005 | WO2005026194A3 Granulysin peptides and methods of use thereof |
| 06/09/2005 | WO2004033483A3 Liposomal system and method of using same |
| 06/09/2005 | US20050123553 Immunogenic for use in diagnosis, vaccination and/or treatment of amyloid fibril disorders such as Alzheimers disease; vaccines |
| 06/09/2005 | US20050123541 Anti-TNF antibodies, compositions, methods and uses |
| 06/09/2005 | US20050123540 administering synergistic antibodies for treatment of lymphocytic lymphomas and leukemia; immunotherapy |
| 06/09/2005 | CA2547086A1 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof |
| 06/08/2005 | EP1537137A2 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 06/08/2005 | CN1625565A Antibodies to non-functional P2X7 receptor, diagnosis and treatment of cancers and other conditions |
| 06/07/2005 | US6903186 Analogues of GLP-1 |
| 06/07/2005 | US6902736 Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same |
| 06/07/2005 | CA2222482C Non-virulent mycoplasma synoviae and vaccine thereof |
| 06/02/2005 | WO2005049640A2 Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof |
| 06/02/2005 | WO2005049639A2 Compositions and methods for protein isolation |
| 06/02/2005 | WO2005049638A2 Amniotic-derived peptide and uses thereof |
| 06/02/2005 | WO2005049636A2 Method of analyzing protein |
| 06/02/2005 | WO2005030792A3 Quinoline potassium channel inhibitors |
| 06/02/2005 | WO2005025497A3 Hpv cd8+ t-cell epitopes |
| 06/02/2005 | WO2005010026A3 Methods for detecting activation of t-cells by mhc binding peptides |
| 06/02/2005 | WO2004094457A3 Stable rgd peptidomimetic composition |
| 06/02/2005 | WO2004092195A3 Dendritic cell binding proteins and uses thereof |
| 06/02/2005 | WO2004052918A3 Peptides and methods for deactivation of organophosphorus-based nerve agents and insecticides |
| 06/02/2005 | US20050119465 Glycosylated follicle stimulating hormone for use as therapeutic tool in treatment of reproductive disorders |
| 06/02/2005 | US20050119273 Small molecule toll-like receptor (TLR) antagonists |
| 06/02/2005 | US20050119186 Potent peptide inhibitors and methods of use |
| 06/02/2005 | US20050118099 Thiol-mediated drug attachment to targeting peptides |
| 06/01/2005 | EP1536234A2 Soluble CTLA4 mutant molecules and uses thereof |
| 06/01/2005 | EP1534749A2 Variant integrin polypeptides and uses thereof |
| 06/01/2005 | EP1534736A2 Nogo receptor antagonists |
| 06/01/2005 | CN1622995A Receptor nucleic acids and polypeptides |
| 05/26/2005 | WO2005047309A2 Prophylactic and therapeutic monoclonal antibodies |
| 05/26/2005 | WO2005047308A2 Peptide-based diagnostic reagents for sars |
| 05/26/2005 | WO2005047306A2 A prion-like form of cpeb and related compositions and methods |
| 05/26/2005 | WO2005047305A2 Cellular membrane protein assay |
| 05/26/2005 | WO2005030791A3 Isoquinolinone potassium channel inhibitors |
| 05/26/2005 | US20050113584 On solid support (polyamide) via condensation and dehydration; chromatography |
| 05/26/2005 | US20050113565 Pegylated factor VII glycoforms |
| 05/26/2005 | US20050112134 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease |
| 05/26/2005 | US20050112119 Antibodies which bind human CXCR3 |
| 05/26/2005 | CA2544688A1 Cellular membrane protein assay |
| 05/25/2005 | EP1533318A1 Prodrugs of thrombin inhibitors |
| 05/24/2005 | CA2157792C N-(3-piperidinyl-carbonyl)-beta-alanine derivatives as paf antagonists |
| 05/19/2005 | WO2005044840A2 Modulation of anergy and methods for isolating anergy-modulating compounds |
| 05/19/2005 | WO2005044839A2 Stabilized alpha helical peptides and uses thereof |
| 05/19/2005 | WO2005044838A2 Cd4+ epitopes of bone morphogenetic proteins |
| 05/19/2005 | WO2005021575A3 Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties |
| 05/19/2005 | WO2004111075A8 Alternative reading frame polypeptides for treatment |
| 05/19/2005 | WO2004099232A3 Selective r-cadherin antagonists and methods |
| 05/19/2005 | WO2004094452A3 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus |
| 05/19/2005 | WO2004072094A3 Hmgb1 modulator binding domain |
| 05/19/2005 | WO2004060912A3 Chimeric capsid proteins and expression vectors for monocistronic expression of multiple genes |
| 05/19/2005 | WO2004024749A3 Thermostable reverse transcriptases and uses thereof |
| 05/19/2005 | US20050106663 viral vector containing a polynucleotide sequence contains two different affinity tag sequences, one of the two affinity tag sequences encodes streptavidin-binding peptide and other encodes calmodulin binding peptide |
| 05/19/2005 | US20050106571 Homodimeric taste receptor for use in identifying modulator of taste; food processing and flavors |
| 05/19/2005 | CA2830063A1 Stabilized alpha helical peptides and uses thereof |
| 05/19/2005 | CA2544223A1 Stabilized alpha helical peptides and uses thereof |
| 05/12/2005 | WO2005042562A2 New coupling agents for peptide synthesis |
| 05/12/2005 | WO2005042561A2 Neural regeneration peptides and methods of use |
| 05/12/2005 | WO2005042560A2 Non-viral delivery of compounds to mitochondria |
| 05/12/2005 | WO2005042559A2 Capture and release based isotope tagged peptides and methods for using the same |
| 05/12/2005 | WO2005026192A3 Hpv cd8+ t-cell epitopes |